These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 24964759

  • 1. Long-term hearing loss after chemoradiation in patients with head and neck cancer.
    Theunissen EA, Zuur CL, Bosma SC, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van der Molen L, Rasch CR, Dreschler WA, Balm AJ.
    Laryngoscope; 2014 Dec; 124(12):2720-5. PubMed ID: 24964759
    [Abstract] [Full Text] [Related]

  • 2. A new grading system for ototoxicity in adults.
    Theunissen EA, Dreschler WA, Latenstein MN, Rasch CR, van der Baan S, de Boer JP, Balm AJ, Zuur CL.
    Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):711-8. PubMed ID: 24820112
    [Abstract] [Full Text] [Related]

  • 3. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA.
    Audiol Neurootol; 2006 Oct; 11(5):318-30. PubMed ID: 16983183
    [Abstract] [Full Text] [Related]

  • 4. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Schornagel JH, Dreschler WA, Rasch CR, Balm AJ.
    J Clin Oncol; 2007 Aug 20; 25(24):3759-65. PubMed ID: 17704425
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
    Zuur CL, Simis YJ, Lamers EA, Hart AA, Dreschler WA, Balm AJ, Rasch CR.
    Int J Radiat Oncol Biol Phys; 2009 Jun 01; 74(2):490-6. PubMed ID: 19135315
    [Abstract] [Full Text] [Related]

  • 6. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Verkaik RS, Schornagel JH, Balm AJ, Dreschler WA, Rasch CR.
    Radiother Oncol; 2008 Oct 01; 89(1):38-43. PubMed ID: 18706728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE, Meyer AC, Adams GL, Ondrey FG.
    Am J Otolaryngol; 2006 Oct 01; 27(2):76-80. PubMed ID: 16500467
    [Abstract] [Full Text] [Related]

  • 9. Predictors of hearing acuity: cross-sectional and longitudinal analysis.
    Linssen AM, van Boxtel MP, Joore MA, Anteunis LJ.
    J Gerontol A Biol Sci Med Sci; 2014 Jun 01; 69(6):759-65. PubMed ID: 24149430
    [Abstract] [Full Text] [Related]

  • 10. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT.
    Arch Otolaryngol Head Neck Surg; 1997 Sep 01; 123(9):978-81. PubMed ID: 9305250
    [Abstract] [Full Text] [Related]

  • 11. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1320-5. PubMed ID: 17418969
    [Abstract] [Full Text] [Related]

  • 12. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1393-402. PubMed ID: 15817342
    [Abstract] [Full Text] [Related]

  • 13. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer.
    Burger AVM, Duinkerken CW, van Sluis KE, de Boer JP, Navran A, Lanting CP, Jóźwiak K, Dreschler WA, Balm AJM, Zuur CL.
    Eur Arch Otorhinolaryngol; 2024 Sep 06. PubMed ID: 39242413
    [Abstract] [Full Text] [Related]

  • 14. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S.
    J Cancer Res Ther; 2020 Sep 06; 16(3):539-545. PubMed ID: 32719264
    [Abstract] [Full Text] [Related]

  • 15. Hearing outcomes following microvascular decompression for hemifacial spasm.
    Shah A, Nikonow T, Thirumala P, Hirsch B, Chang Y, Gardner P, Balzer J, Habeych M, Crammond D, Burkhart L, Horowitz M.
    Clin Neurol Neurosurg; 2012 Jul 06; 114(6):673-7. PubMed ID: 22410649
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy.
    Niemensivu R, Saarilahti K, Ylikoski J, Aarnisalo A, Mäkitie AA.
    Eur Arch Otorhinolaryngol; 2016 Sep 06; 273(9):2509-14. PubMed ID: 26685859
    [Abstract] [Full Text] [Related]

  • 19. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses.
    Lin HY, Shih SC, Chuang CK, Lee KS, Chen MR, Lin HC, Chiu PC, Niu DM, Lin SP.
    Mol Genet Metab; 2014 Apr 06; 111(4):533-8. PubMed ID: 24594444
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.